Dr. Rekart is board certified in Internal Medicine and Infectious Disease with additional training in Tropical Medicine & Hygiene, Clinical Epidemiology and Public Health. He served as the Director of STI/HIV Prevention and Control at the BC Centre for Disease Control (BCCDC) for 25 years from 1985-2010. During that period he was also the Co-Chair for the XIth International Conference on AIDS (Vancouver 1996) and the Principal Investigator for a $5.6M CIDA-sponsored project in southern Vietnam that established a network of 9 STD clinics for low income sex workers in 4 provinces. He retired from the BCCDC in 2010 and moved to the UBC School of Population and Public Health where he helped to grow and develop the Global and Indigenous Health theme. Dr. Rekart worked with Medecins sans Frontieres (MSF – Doctors Without Borders) as the HIV and Outpatient Doctor at a comprehensive healthcare clinic in Swaziland from May 2013 to May 2014. For 7 weeks over the 2014 Christmas holidays, he took up an MSF Ebola assignment in Sierra leone.

The James M. Robinson Award 1996

phone: 6043126555
5838 Berton Avenue
Unit 103
Vancouver, BC V6S 0A5

Rekart ML. Caring for Sex Workers. BMJ 2015;351:h4011.

Rekart ML. Retiring to Ebola. BC Med Journ 2015; 57 (5): 186-8.

Gilbert M, Cook D, Steinberg M, Kwag M, Robert W, Doupe G, Krajden M, Rekart M. Targeting screening and social marketing to increase detection of acute HIV infection 
in men who have sex with men in Vancouver, British Columbia. AIDS 2013:27(16):2649-54. 

Rekart ML, Gilbert M, Meza R, Kim PH, Chang M, Money DM, Brunham RC. Chlamydia public health programs and the epidemiology of pelvic inflammatory disease and 
ectopic pregnancy. J Infect Dis 2013; 207: 30-38.

Batteiger BE, Xu F, Johnson RE, Rekart ML. Protective immunity to Chlamydia trachomatis genital infection: evidence from human studies. J Infect Dis 2010; 201(Suppl 2): 

Rekart ML, Brunham RC. Chapter 99: STD Vaccines. In: Holmes KK, Sparling PF, Stamm WE, Piot P, Wasserheit JN, Corey L, Cohen MS, Watts DH, Nelson RA, eds. 
Sexually Transmitted Diseases. 4th ed. New York: McGraw-Hill, 2008, pp. 1913-36. 

Rekart ML, Brunham RC. Epidemiology of Chlamydial infection: are we losing ground? Sex Transm Infect 2008; 84: 87-91.

Brunham RC, Rekart ML. The arrested immunity hypothesis and the epidemiology of Chlamydia control. Sex Transm Dis 2008; 35: 53-4.
Rekart ML. Sex-work harm reduction. Lancet 2005; 366: 2123-34.

Brunham RC, Pourbohloul B, Mak S, White R, Rekart ML. The unexpected impact of a Chlamydia trachomatis infection control program on susceptibility to reinfection. J Infect Dis 2005; 192: 836-44.

Rekart ML, Rekart JT, Patrick DM, Brunham RC. International health: Five reasons why Canadians should get involved. Can J Public Health 2003; 94 (4): 258-9. 

Rekart ML, Patrick DM, Chakraborty B, Maginley JJL, Jones HD, Bajdik CD. Targeted mass treatment for syphilis with oral azithromycin. Lancet 2003; 361: 313-4.

Rekart ML. Sex in the city: Sexual behaviour, societal change, and STIs in Saigon. Sex Transm Infect 2002; 78 (Suppl 1): i47-54.

Strathdee SA, Patrick DM, Currie S, Cornelisse PGA, Rekart ML, et al. Needle Exchange is not Enough: Lessons from the Vancouver Injection Drug Use Study. AIDS 
1997; 11: F59-65.

Rekart ML. The Toxicity and Local Effects of the Spermicide Nonoxynol 9. J Acquir Immune Defic Syndr & Hum Retrovirol 1992; 5(4): 425-7. 

SPPH 581I Morbidity and Mortality in Low and Middle Income Countries
SPPH 581J Overview of Global Health
SPPH 581K Practical Knowledge and Skills for Working in Global Health